Main Responsibilities of the National Medical Products Administration
(1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics.
(2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system.
(3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof.
(4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA’s responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.
(5) To undertake post-market risk management for drugs, medical devices and cosmetics; to organize the monitoring, evaluation, and handling of adverse drug reactions, medical device adverse events, and cosmetic adverse reactions; to undertake emergency response management for drugs, medical devices and cosmetics in accordance with law.
(6) To undertake management of qualifications for licensed pharmacists; to formulate regulations of qualifications for licensed pharmacists, and guide and supervise the registration of licensed pharmacists.
(7) To organize and guide the supervision and inspection of drugs, medical devices and cosmetics; to develop the inspection system, investigate and punish illegal activities during the registration process for drugs, medical devices and cosmetics in accordance with law, and organize and guide the investigation and punishment of illegal activities during the manufacturing process in line with NMPA’s responsibilities.
(8) To engage in international exchange and cooperation in the regulation of drugs, medical devices and cosmetics, and participate in developing relevant international regulatory rules and standards.
(9) To guide the work of drug regulatory departments of all provinces, autonomous regions, and municipalities directly under the Central Government.
(10) To complete other tasks assigned by the CPC Central Committee and the State Council.
下一篇:原卫生部《进口非特殊用途化妆品备案凭证》 »
相关文章:
- [ABOUT]Cooperation Process of Imported Cosmetics Registration
- [ABOUT]Documents Preparation
- [ABOUT]Procedure
- [ABOUT]EVENTS
- [ABOUT]Commitments
- [ABOUT]Cooperation cases
- [ABOUT]Contact Us
- [ABOUT]Services
- [ABOUT]BeijingTianjianhuacheng International Investment Co.,Ltd
- [ABOUT]How to choose a professional agency?
相关推荐:
- [审批动态]2022年07月14日化妆品不予批准决定书邮寄详情单
- [申报资讯]10自贸区实施进口非特殊用途化妆品备案管理
- [审批动态]2023年04月21日化妆品决定书送达信息发布
- [申报资讯]《牙膏监督管理办法》政策解读
- [申报资讯]关于化妆品等卫生行政许可受理有关事宜的公告
- [常见问题]关于标签、销售证明、命名依据|北京市化妆品审评检查中心关于普通化妆品备案常见问题一问一答(第十期)
- [常见问题]化妆品申报包装标签中字号和英文标识问题
- [常见问题]多色号系列进口普通化妆品按《化妆品注册和备案检验工作规范》抽样进行毒理学试验的,可以使用毒理学实验报告的复印件吗?
- [常见问题]进口非特殊用途化妆品备案境内责任人的责任及其变更办法?
- [审批动态]2022年07月29日化妆品批准证明文件(HSCB)待领取信息发布
-
86-010-84828041/42
400-6167-168
zhuceabc@zhuceabc.com
咨询微信:
13601366497(化妆品类)
1801335159(特殊食品类)